Ophthalmology Department, Medical University of Bialystok, 24a M.Sklodowskiej-Curie, 15-276, Bialystok, Poland.
Department of Rheumatology and Internal Diseases, Medical University of Bialystok, 24a M. Sklodowskiej-Curie, 15-276, Bialystok, Poland.
Graefes Arch Clin Exp Ophthalmol. 2024 May;262(5):1475-1487. doi: 10.1007/s00417-023-06342-4. Epub 2023 Dec 22.
The aim of this study was to investigate choroidal parameters in patients with systemic sclerosis (SSc) using enhanced depth imaging spectral-domain optical coherence tomography (EDI-SD-OCT) and to determine their relationships with clinical variables and ocular features.
Thirty-three patients with SSc and 40 controls were enrolled. The groups did not differ with regard to age, sex, and axial length. The mean choroidal thickness and volume were obtained in each conventional Early Treatment of Diabetic Retinopathy Study grid subfield. The choroidal vascularity index (CVI), which provides a quantitative analysis of vasculature by calculating the proportion of the luminal area (LA) to the total choroidal area (TCA), was determined.
Lower choroidal thickness and volume were observed in the SSc group. The CVI was significantly higher in SSc patients, whereas the TCA, LA, and stromal area were significantly lower in the SSc group; however, the significant difference of the stromal component was more pronounced than that of the luminal component. Regression analyses did not identify any clinical factors associated with the CVI (except Ca-blocker use), central macular thickness, or volume. No significant differences in choroidal parameters were found within the SSc subtypes (diffuse cutaneous systemic sclerosis (dcSSc) vs. limited cutaneous systemic sclerosis (lcSSc)), or between eyes stratified according to SSc pattern (early, active, or late) using nailfold capillaroscopy (p > 0.05 for all).
Our results, with notably higher CVI values, may shed new light on choroidal impairment in patients with SSc. Stromal involvement appeared to dominate the vascular component.
本研究旨在使用增强深度成像谱域光相干断层扫描(EDI-SD-OCT)研究系统性硬化症(SSc)患者的脉络膜参数,并确定其与临床变量和眼部特征的关系。
纳入 33 例 SSc 患者和 40 例对照者。两组在年龄、性别和眼轴长度方面无差异。在每个常规早期糖尿病视网膜病变研究网格子区域中获得平均脉络膜厚度和体积。通过计算管腔面积(LA)与总脉络膜面积(TCA)的比例,得出脉络膜血管指数(CVI),对脉络膜血管进行定量分析。
SSc 组的脉络膜厚度和体积较低。SSc 患者的 CVI 显著升高,而 SSc 患者的 TCA、LA 和基质面积显著降低;然而,基质成分的显著差异比管腔成分更明显。回归分析未发现任何与 CVI(除钙通道阻滞剂使用外)、中央黄斑厚度或体积相关的临床因素。在 SSc 亚型(弥漫性皮肤系统性硬化症(dcSSc)与局限性皮肤系统性硬化症(lcSSc))内或根据甲褶毛细血管镜(NVC)分层的 SSc 模式(早期、活动期或晚期)的眼中,均未发现脉络膜参数存在显著差异(所有 p 值均>0.05)。
我们的结果表明 CVI 值显著升高,可能为 SSc 患者脉络膜损伤提供新的认识。基质参与似乎主导血管成分。